Véronique Vergé
Institut Gustave Roussy(FR)
Publications by Year
Research Areas
PARP inhibition in cancer therapy, Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, Cancer Genomics and Diagnostics
Most-Cited Works
- → Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial(2016)186 cited
- → Cutting Edge Communication: In Vitro Generation of Dendritic Cells from Human Blood Monocytes in Experimental Conditions Compatible for In Vivo Cell Therapy(2000)50 cited
- → Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights(2021)33 cited
- → Reduced Venetoclax Exposition to Seven Days of Azacitidine Is Efficient in Treatment-Naïve Patients with Acute Myeloid Leukemia(2022)30 cited
- → Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life Experience(2022)28 cited
- → In Vitro Production of Dendritic Cells from Human Blood Monocytes for Therapeutic Use(2001)27 cited
- → Presence of primitive lymphoid progenitors with NK or B potential in ex vivo expanded bone marrow cell cultures(2000)22 cited
- → Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors(2023)19 cited
- → Fas‐Mediated Apoptosis of Mouse Embryo Stem Cells: Its Role During Embryonic Development(2000)14 cited
- → Outcomes of Transplant-Eligible Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Salvage Chemotherapy: The Gustave Roussy Experience(2020)10 cited